Oral liquid for treating cold, cough, bronchitis and asthma and preparation method thereof

Abstract

The invention discloses oral liquid for treating cold, cough, bronchitis and asthma and relates to a medicine or food for treating the cold, cough, bronchitis and asthma. The oral liquid is prepared from the following components in parts by weight: 1-4000 parts of fresh ginger, 1-3000 parts of garlic, 1-4000 parts of red dates, 1-3500 parts of brown sugar, 0.08-25 parts of liquorice root extract,0.005-1.5 parts of opium powder and 50-60000 parts of water. The oral liquid disclosed by the invention has the beneficial effects that when in treatment for cold, cough, bronchitis and asthma, a patient does not need to take antibacterial medicines, the treatment effect is better, and the oral liquid also can be drunk as a functional beverage.

Description

technical field [0001] The invention relates to a medicine or food material for treating cold, cough, chronic bronchitis and asthma, in particular to an oral liquid for treating cold, cough, bronchitis and asthma. The invention also relates to a preparation method of the oral liquid for treating colds, coughs, bronchitis and relieving asthma. Background technique [0002] At present, the medical model for treating colds and coughs: patients take cold and cough medicines orally, and at the same time take antibacterial drugs orally or intravenously infuse antibacterial drugs for treatment. The medical model for treating bronchitis: the patient takes oral bronchitis drugs, and at the same time takes oral antibiotics or intravenous infusion of antibacterial drugs for treatment. The medical mode of treating asthma: the patient takes oral anti-asthmatic drugs, and at the same time takes oral or intravenous antibacterial drugs for treatment. [0003] When the above-mentioned exis...

AI Technical Summary

Problems solved by technology

[0003] When the above-mentioned existing technical solutions are used for treating patients, excessive use of antibacterial drugs is inevitable. According to the notice of Guowei Yifa [2016] No. 43 "National Action Plan for Containing Bacterial Resistance 2016-2020" (Abstract 1 , Preface): Due to various factors such as insufficient research and development capabilities of new antibacterial drugs, pharmacies selling antibacterial drugs without prescriptions, irrational use of antibacterial drugs in medical and breeding fields, waste discharge from pharmaceutical companies is not up to standard, and people’s awareness of rational drug use is not high. Bacterial drug resistance The problem is becoming more and more prominent

Bacterial drug resistance ultimately affects human health, but the factors and consequences of bacterial drug resistance go beyond the health field, and bring adverse effects such as increased biosecurity threats, environmental pollution, and economic development constraints to human society, and urgently need to be strengthened. Multi-sector and multi-field collaborative planning and joint response

Images